Jordi Remon (@jordiremon) 's Twitter Profile
Jordi Remon

@jordiremon

Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC

ID: 840695654120849408

calendar_today11-03-2017 22:47:18

420 Tweet

3,3K Takipçi

99 Takip Edilen

Jordi Remon (@jordiremon) 's Twitter Profile Photo

For pts w EGFRm with Osi-Progression NSCLC not homogeneous benefit in PFS with🩸antiangiogenic + io+CT vs CT and no mature OS benefit Ph 3 HARMONI-3 trial (ivonescimab (bispecific VEGF/PD1 Ab)+ CT vs CT is pending. Data in Chinese pts looks similar to previous (HARMONI-A) #ASCO24

For pts w EGFRm with Osi-Progression NSCLC not homogeneous benefit in PFS with🩸antiangiogenic + io+CT vs CT and no mature OS benefit
Ph 3 HARMONI-3 trial (ivonescimab (bispecific VEGF/PD1 Ab)+ CT vs CT is pending. Data in Chinese pts looks similar to previous (HARMONI-A) #ASCO24